Expertise in
24
conditions

Jakob R. Izbicki

Martini Str. 52, 
Hamburg, HH, DE 
Expertise in
24
conditions
Martini Str. 52, 
Hamburg, HH, DE 

Overview

Jakob Izbicki practices practicing medicine in Hamburg, Germany.

Mr. Izbicki is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Esophageal Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

He is actively involved in clinical research, co-authoring 455 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Martini Str. 52, Hamburg, HH 20246, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Perioperative Chemotherapy (FLOT Protocol) Compared To Neoadjuvant Chemoradiation (CROSS Protocol) in Patients With Adenocarcinoma of the Esophagus
Perioperative Chemotherapy (FLOT Protocol) Compared To Neoadjuvant Chemoradiation (CROSS Protocol) in Patients With Adenocarcinoma of the Esophagus
Enrollment Status: Unknown
Publish Date: May 08, 2024
Intervention Type: Radiation, Drug
Study Drugs: 5-Fluorouracil, Leucovorin, Oxaliplatin, Docetaxel, Carboplatin, Paclitaxel
Study Phase: Phase 3
Pulmonary Wedge Resection Plus Parietal Pleurectomy (WRPP) Versus Parietal Pleurectomy (PP) for the Treatment of Recurrent Primary Pneumothorax
Pulmonary Wedge Resection Plus Parietal Pleurectomy (WRPP) Versus Parietal Pleurectomy (PP) for the Treatment of Recurrent Primary Pneumothorax
Enrollment Status: Unknown
Publish Date: November 02, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
Prospective, Multicenter Study to Evaluate the Safety and Performance of a syntHetic Tissue Sealant in Reducing fluId lEakage Following Elective hepatobiLiary anD Pancreatic Surgery
Prospective, Multicenter Study to Evaluate the Safety and Performance of a syntHetic Tissue Sealant in Reducing fluId lEakage Following Elective hepatobiLiary anD Pancreatic Surgery
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Device
Study Phase: Not Applicable
Sequential Neoadjuvant Chemoradiotherapy (CRT) Followed by Curative Surgery vs. Primary Surgery Alone for Resectable, Non-metastasized Pancreatic Adenocarcinoma
Sequential Neoadjuvant Chemoradiotherapy (CRT) Followed by Curative Surgery vs. Primary Surgery Alone for Resectable, Non-metastasized Pancreatic Adenocarcinoma
Enrollment Status: Terminated
Publish Date: May 11, 2018
Intervention Type: Radiation, Drug, Procedure
Study Phase: Phase 3
View 3 Less Clinical Trials

455 Total Publications

Corrigendum to 'Transforming Orthotopic Liver Transplantation: Innovative Dry-Lab Simulation Model in Mice'.
Corrigendum to 'Transforming Orthotopic Liver Transplantation: Innovative Dry-Lab Simulation Model in Mice'.
Journal: Current problems in surgery
Published: July 23, 2026

Frequently Asked Questions about Jakob R. Izbicki

Is Jakob R. Izbicki a top-rated expert for Esophageal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Jakob R. Izbicki is classified as an Elite expert for Esophageal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jakob R. Izbicki participate in research or clinical trials?

Yes. Jakob R. Izbicki has published 455 articles and abstracts on conditions like Esophageal Cancer. You can view a list of Jakob R. Izbicki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Izbicki's expertise for a condition
ConditionClose
View All 18 Advanced Conditions
View All 54 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile